UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3448-3452

2012

Volltextzugriff (PDF)

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1649-1655

2007

Volltextzugriff (PDF)

In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

Antimicrobial Agents and Chemotherapy, 2004-03, Vol.48 (3), p.1034-1036

2004

Volltextzugriff (PDF)

A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021

Antimicrobial agents and chemotherapy, 2023-10, Vol.67 (10), p.e0034923-e0034923

2023

Volltextzugriff (PDF)

Factors Associated with Neutropenia Post-Heart Transplantation

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S482-S482

2020

Volltextzugriff (PDF)

Putting the IMPACT Study into Perspective: Should CMV Prophylaxis Be Extended to 6 Months for High Risk Transplants?

American journal of transplantation, 2011-01, Vol.11 (1), p.6-7

Snydman, D. R.

2011

Volltextzugriff (PDF)

Predicting Bacteremia in Patients with Sepsis Syndrome

The Journal of infectious diseases, 1997-12, Vol.176 (6), p.1538-1551

1997

Volltextzugriff (PDF)

Treatment of severe pneumonia in hospitalized patients : results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin

Antimicrobial agents and chemotherapy, 1994, Vol.38 (3), p.547-557

1994

Volltextzugriff (PDF)

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group

Antimicrobial Agents and Chemotherapy, 1997-09, Vol.41 (9), p.2047-2049

1997

Volltextzugriff (PDF)

Exposure to Cytomegalovirus from the Donated Organ Is a Risk Factor for Bacteremia in Orthotopic Liver Transplant Recipients

Clinical infectious diseases, 1996-09, Vol.23 (3), p.468-474

1996

Volltextzugriff (PDF)

Limulus Amebocyte Lysate Assay for Detection of Endotoxin in Patients with Sepsis Syndrome

Clinical infectious diseases, 1998-09, Vol.27 (3), p.582-591

1998

Volltextzugriff (PDF)

The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients

The American journal of medicine, 1997-08, Vol.103 (2), p.106-113

1997

Volltextzugriff (PDF)

Vancomycin-Resistant Enterococcus Infections in Solid Organ Transplantation: The American Society of Transplantation Infectious Diseases Guidelines 3rd Edition

American journal of transplantation, 2013, Vol.13, p.59-67

2013

Volltextzugriff (PDF)

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

Antimicrobial agents and chemotherapy, 2003-02, Vol.47 (2), p.831-831

2003

Volltextzugriff (PDF)

Surveillance Cultures of Blood, Urine, and Throat Specimens Are Not Valuable for Predicting Cytomegalovirus Disease in Liver Transplant Recipients

Clinical infectious diseases, 1997-05, Vol.24 (5), p.824-829

1997

Volltextzugriff (PDF)

Primary Cytomegalovirus Infection in Liver Transplant Recipients: Comparison of Infections Transmitted Via Donor Organs and Via Transfusions

Clinical infectious diseases, 1996-08, Vol.23 (2), p.292-297

1996

Volltextzugriff (PDF)

Use of Valganciclovir for Prevention and Treatment of Cytomegalovirus Disease

Clinical infectious diseases, 2008-01, Vol.46 (1), p.28-29

Snydman, David R.

2008

Volltextzugriff (PDF)

Reply to van Hal et al

Clinical infectious diseases, 2011-12, Vol.53 (11), p.1167-1168

2011

Volltextzugriff (PDF)

Prevention of cytomegalovirus disease with intravenous immune globulin

Transplantation proceedings, 1991-04, Vol.23 (2), p.20-25

SNYDMAN, D. R

1991

Volltextzugriff (PDF)

THE ASSOCIATION BETWEEN CYTOMEGALOVIRUS IMMUNE GLOBULIN (CMVIG) USE AND LONG-TERM RECIPIENT AND GRAFT SURVIVAL IN PEDIATRIC HEART TRANSPLANTATION RECIPIENTS: 543

Transplantation, 2010-07, Vol.90, p.29

2010

Volltextzugriff (PDF)

Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients

Transplantation proceedings, 1993-10, Vol.25 (5), p.22-24

1993

Volltextzugriff (PDF)

A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection

Transplantation proceedings, 1994-10, Vol.26 (5), p.23-27

1994

Volltextzugriff (PDF)

Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation

Clinical transplantation, 1997-10, Vol.11 (5pt1), p.432-437

1997

Volltextzugriff (PDF)

Clinical and Epidemiological Predictors of Recurrent Cytomegalovirus Disease in Orthotopic Liver Transplant Recipients

Clinical infectious diseases, 1997-08, Vol.25 (2), p.314-317

1997

Volltextzugriff (PDF)

Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis

Journal of Bacteriology, 1982-08, Vol.151 (2), p.686-691

1982

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(81)
Französisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021

Factors Associated with Neutropenia Post-Heart Transplantation

Putting the IMPACT Study into Perspective: Should CMV Prophylaxis Be Extended to 6 Months for High Risk Transplants?

Predicting Bacteremia in Patients with Sepsis Syndrome

Treatment of severe pneumonia in hospitalized patients : results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group

Exposure to Cytomegalovirus from the Donated Organ Is a Risk Factor for Bacteremia in Orthotopic Liver Transplant Recipients

Limulus Amebocyte Lysate Assay for Detection of Endotoxin in Patients with Sepsis Syndrome

The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients

Vancomycin-Resistant Enterococcus Infections in Solid Organ Transplantation: The American Society of Transplantation Infectious Diseases Guidelines 3rd Edition

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

Surveillance Cultures of Blood, Urine, and Throat Specimens Are Not Valuable for Predicting Cytomegalovirus Disease in Liver Transplant Recipients

Primary Cytomegalovirus Infection in Liver Transplant Recipients: Comparison of Infections Transmitted Via Donor Organs and Via Transfusions

Use of Valganciclovir for Prevention and Treatment of Cytomegalovirus Disease

Reply to van Hal et al

Prevention of cytomegalovirus disease with intravenous immune globulin

THE ASSOCIATION BETWEEN CYTOMEGALOVIRUS IMMUNE GLOBULIN (CMVIG) USE AND LONG-TERM RECIPIENT AND GRAFT SURVIVAL IN PEDIATRIC HEART TRANSPLANTATION RECIPIENTS: 543

Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients

A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection

Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation

Clinical and Epidemiological Predictors of Recurrent Cytomegalovirus Disease in Orthotopic Liver Transplant Recipients

Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis

Aktive Filter

Suchergebnisse filtern